Monday, June 15, 2026

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

AWS lights up Korean dev scene with GenAI Amazon Q

AWS enhances its generative AI service, Amazon Q Developer, to support Korean, aiding local developers in various tasks.

North Korea’s 9th Workers’ Party Congress: What to Expect in February 2026?

North Korea plans to hold the 9th Workers' Party Congress in late February, focusing on governance direction and policy review.

Tag: GLP-1 treatments

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Teen Prescriptions for GLP-1 Obesity Drugs Surge in Korea, Raising Misuse Concerns

Surge in GLP-1 obesity treatment prescriptions among teens raises concerns over misuse and potential health risks.

Will Novo Nordisk’s 50% Price Cut on Wegovy Spark a Price War in Korea’s Obesity Drug Market?

Novo Nordisk's price cuts for GLP-1 obesity treatments in the U.S. may influence South Korean market dynamics, though immediate effects seem limited.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.